New activators of SIRT1 enzyme for the treatment of cardiovascular and cardiometabolic pathologies

The present invention targets a class of compounds able to activate the enzyme SIRT1 in humans by regulating numerous metabolic functions. The appropriately designed compounds could be used in pharmaceutical formulations, preferably in the treatment or prevention of cardiometabolic diseases